The range of neurological syndromes associated with glutamic acid decarboxylase antibodies

Cover Page

Cite item


Neurological syndromes caused by production of antibodies to glutamic acid decarboxylase (GAD65) are a relatively new area of modern clinical neurology, which is of great theoretical and practical interest. High titer of identified antibodies is a not always specific, but highly sensitive, marker for autoimmune CNS disorders. The authors present their own clinical observations and an analysis of the literature on a wide phenotypic range of GAD65-associated pathologies.


About the authors

M. Yu. Krasnov

Research Center of Neurology

Russian Federation, Moscow

E. V. Pavlov

Research Center of Neurology

Russian Federation, Moscow

Margarita V. Ershova

Research Center of Neurology

Russian Federation, Moscow

Sofiya L. Timerbaeva

Research Center of Neurology

Russian Federation, Moscow

Sergey N. Illarioshkin

Research Center of Neurology

Author for correspondence.
ORCID iD: 0000-0002-2704-6282

D. Sci. (Med.), Prof., Corr. Member of the Russian Academy of Sciences, Deputy Director, Head, Department for brain research

Russian Federation, Moscow


  1. Каламкарян А.А., Мордовцев В.Н., Трофимова Л.Я. Клиническая дерматология. Редкие и атипичные дерматозы. Ереван: Айастан,1989.
  2. Краснов М.Ю., Тимербаева С.Л., Иллариошкин С.Н. Генетика наследственных форм дистонии. Анн. клин. и эксперим. неврол. 2013; 2: 55–62.
  3. Мальмберг С.А., Дадали Е.Л., Жумаханов Д.Б. и др. Синдром ригидного человека с дебютом в грудном возрасте. Нервно-мышечные болезни. 2015; 2: 38–43.
  4. Alexopoulos H., Dalakas M.C. A clinical update on the immunopathogenesis of Stiff Person Syndrome. Eur. J. Clin. Invest. 2010; 40: 1018–1025.
  5. Arino H., Gresa-Arribas N., Blanco Y. et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies: Immulologic profile and longterm effect of immunotherapy. JAMA Neurol. 2014; 71: 1009–1016.
  6. Boronat A., Sabater L., Saiz A. et al. GABAB receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disorders. Neurology. 2011; 76: 795–800.
  7. Braun J., Sieper J. Ankylosing spondylitis. Lancet. 2007; 369 (9570): 1379–1390.
  8. Chen Y.-T. Glycogen storage diseases. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D. (eds). The Metabolic and Molecular Bases of Inherited Disease. Vol. I. NY: McGraw-Hill, 2001: 1537–1551.
  9. Dayalu P., Teener J.W. Stiff Person syndrome and other anti-GADassociated neurologic disorders. Semin Neurol. 2012; 32: 544–549.
  10. Drost G., Verrips A., Hooijkaas Н. et al. Glutamic acid decarboxylase antibodies in Satoyoshi syndrome. Ann. Neurol. 2004; 55: 450–451.
  11. Ehlayel M.S., Lacassie Y. Satoyoshi syndrome: an unusual postnatal multisystemic disorder. Am. J. Med. Genet. 1995; 57: 620-5.
  12. Graus F., Delattre J.Y., Antoine J.C. et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J. Neurol. Neurosurg. Psychiatry. 2004; 75: 1135–1140.
  13. Gultekin S.H. Recent developments in paraneoplastic disorders of the nervous system. Surg. Pathol. Clin. 2015; 8: 89–99.
  14. Hadjivassiliou M., Sanders D.S., Woodroofe N. et al. Gluten ataxia. Cerebellum. 2008; 7: 494–498.
  15. Honnorat J., Saiz A., Giometto B. et al. Cerebellar ataxia with antiglutamic acid decarboxylase antibodies. Arch. Neurol. 2001; 58: 225–230.
  16. Kono S., Miyajima H., Sugimoto M. et al. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer. Intern Med. 2001; 40: 968–971.
  17. Kuchling J., Shababi-Klein J., Nümann A. et al. GAD antibody-associated late-onset cerebellar ataxia in two female siblings. Case Rep. Neurol. 2014; 6: 264–270.
  18. Rakocevic G., Floeter M.K. Autoimmune stiff person syndrome and related myelopathies: Understanding of electrophysiological and immunological processes. Muscle Nerve. 2012; 45: 623–634.
  19. Rüegg S.J., Steck A.J., Fuhr P. Levetiracetam improves paroxysmal symptoms in a patient with stiff-person syndrome. Neurology. 2004; 62: 338.
  20. Saiz A., Blanco Y., Sabater L. et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008; 131: 2553–2563.
  21. Sharma B., Nagpal K., Prakash S. et al. Anti-GAD negative stiff person syndrome with a favorable response to intravenous methylprednisolone: An experience over evidence. Neurol India. 2014; 62: 76–77.
  22. Ueno S., Miyamoto N., Shimura H. et al. Successful immune moderation treatment for progressive encephalomyelitis with rigidity and myoclonus. Intern. Med. 2015; 54: 219–221.
  23. Vulliemoz S., Vanini G., Truffert A. et al. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. BMJ Case Rep. 2009; 2009: bcr09.2008.0977.
  24. Wenninger S., Schoser B. The spectrum of neuromyotonia: clinics, therapy and outcome. Fortschr. Neurol. Psychiatr. 2015; 83: 457–462.
  25. Wu Y., Weber J.L., Vladutiu G.D., Tarnopolsky M.A. Six novel mutations in the myophosphorylase gene in patients with McArdle disease and a family with pseudo-dominant inheritance pattern. Mol. Genet. Metab. 2011; 104: 587–591.

Copyright (c) 2015 Krasnov M.Y., Pavlov E.V., Ershova M.V., Timerbaeva S.L., Illarioshkin S.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies